The proposed settlement would end an ongoing lawsuit against Viatris Inc. (formerly Mylan), the makers of EpiPen, that began in 2016 after public outrage over the company's decision to raise the ...

Chief executive for the now-infamous pharmaceutical company that hiked the price of the EpiPen—that ubiquitous device so many children (and plenty of adults) depend on in the event of a life ...